We are live on
!
Find out more
TCM
Traynor Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
62.36%
This Fund
S&P 500
This Quarter
Est. Return
+17.28%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.9%
AUM
$299M
AUM Growth
+$58.7M
(+24%)
Cap. Flow
+$29.1M
Cap. Flow
% of AUM
9.74%
Top 10 Holdings %
Top 10 Hldgs %
49.2%
Holding
187
New
30
Increased
86
Reduced
50
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Russell2000
UWM
|
+$5.3M |
| 2 |
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
|
+$3.54M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$1.37M |
| 4 |
Biogen
BIIB
|
+$1.29M |
| 5 |
Constellation Brands
STZ
|
+$1.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily S&P Biotech Bear 3X ETF
LABD
|
+$1.29M |
| 2 |
CELG
Celgene Corp
CELG
|
+$778K |
| 3 |
Ecolab
ECL
|
+$571K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$368K |
| 5 |
Gilead Sciences
GILD
|
+$291K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 13.46% |
| 2 | Technology | 13.39% |
| 3 | Consumer Discretionary | 11.28% |
| 4 | Healthcare | 9.4% |
| 5 | Industrials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Cigna
CI
$74.6B
| – | – |
-1,413
| Closed | -$268K |
|
177
Celldex Therapeutics
CLDX
$3.28B
| – | – |
-667
| Closed | -$2K |
|
178
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| – | – |
-11,620
| Closed | -$168K |
|
179
Walt Disney
DIS
$181B
| – | – |
-1,949
| Closed | -$213K |
|
|
180
Ecolab
ECL
$79.9B
| – | – |
-3,817
| Closed | -$571K |
|
181
Kroger
KR
$34.8B
| – | – |
-9,004
| Closed | -$247K |
|
|
182
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$57.2M
| – | – |
-151
| Closed | -$1.29M |
|
183
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
| – | – |
-2,438
| Closed | -$244K |
|
184
Simon Property Group
SPG
$72.3B
| – | – |
-1,413
| Closed | -$245K |
|
|
WP
185
DELISTED
Worldpay, Inc.
WP
| – | – |
-3,035
| Closed | -$239K |
|
|
SGYP
186
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| – | – |
-40,500
| Closed | -$9K |
|
|
SLY
187
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $0 | ﹤0.01% |
+53,336
| New | +$3.54M |
|
Similar funds
SIG
ICM
CAG
ET
MIAS
ORCP
TAL
GC
Traynor Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Traynor Capital Management held 187 positions worth $299M, up 24% from $240M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Traynor Capital Management deployed $29.1M of net new capital in Q1 2019, opening 30 new positions and adding to 86 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 162,532 shares worth $1K.
By sector, the portfolio is most concentrated in Communication Services at 13% of assets, down from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Celgene Corp, an estimated $778K trimmed.
- Traynor Capital Management's largest Q1 2019 buy was ProShares Ultra Russell2000: 162,532 shares worth $1K.
- Traynor Capital Management added most to Biogen in Q1 2019, an estimated $1.29M increase.
- Traynor Capital Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $778K.
- Traynor Capital Management fully exited Direxion Daily S&P Biotech Bear 3X ETF in Q1 2019, selling an estimated $1.29M.
- Traynor Capital Management's ten largest holdings make up 49% of its $299M portfolio in Q1 2019.
- Traynor Capital Management opened 30 new positions and closed 12 in Q1 2019.
- Traynor Capital Management's portfolio value rose 24% quarter-over-quarter to $299M.
Based on Traynor Capital Management's 13F filing for Q1 2019, filed 12 Apr 2019.